Scholar Rock Holding Corp. (SRRK)
46.83
+1.78
(+3.95%)
USD |
NASDAQ |
Dec 11, 16:00
47.19
+0.36
(+0.77%)
After-Hours: 05:10
Scholar Rock Research and Development Expense (Quarterly): 50.06M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 1.338B |
| Lifeward Ltd. | 0.721M |
| Mersana Therapeutics, Inc. | 12.07M |
| Twist Bioscience Corp. | 17.01M |
| ETHZilla Corp. | -- |